Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibitor < inhibitors < inhibits  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000056 (2020) Paolo Verdecchia ; Gianpaolo Reboldi ; Claudio Cavallini ; Giovanni Mazzotta ; Fabio Angeli[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
000185 (2020) Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde]Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
000189 (2020) Yixian Liao [République populaire de Chine] ; Yilu Ye [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yilian Zhuang [République populaire de Chine] ; Liye Chen [République populaire de Chine] ; Jianxin Chen [République populaire de Chine] ; Zining Cui [République populaire de Chine] ; Lijian Huo [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine]Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease.
000331 (2020) Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde]Recent discovery and development of inhibitors targeting coronaviruses
000463 (2020) Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie]Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity?
000467 (2020) I. Aanouz [Maroc] ; A. Belhassan [Maroc] ; K. El Khatabi [Maroc] ; T. Lakhlifi [Maroc] ; M. El Idrissi [Maroc] ; M. Bouachrine [Maroc]Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations.
000540 (2020) Thorsten Kessler [Allemagne] ; Heribert Schunkert [Allemagne]Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
000575 (2020) Salman Ali Khan [Pakistan] ; Komal Zia [Pakistan] ; Sajda Ashraf [Pakistan] ; Reaz Uddin [Pakistan] ; Zaheer Ul-Haq [Pakistan]Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
000720 (2020) Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine]Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
000783 (2020) Junyi Guo ; Zheng Huang ; Li Lin ; Jiagao LvCoronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
000991 (2020) Abdo A. ElfikyAnti-HCV, nucleotide inhibitors, repurposing against COVID-19
000A77 (2009) Xin Chen [Taïwan] ; Chi-Yuan Chou ; Gu-Gang ChangThiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme.
000B11 (????) Joseph Kattan [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban]Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021